Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Trimmed by Bourne Lent Asset Management Inc.

Bourne Lent Asset Management Inc. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 3.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,810 shares of the medical equipment provider’s stock after selling 900 shares during the period. Intuitive Surgical comprises approximately 5.3% of Bourne Lent Asset Management Inc.’s portfolio, making the stock its 7th biggest holding. Bourne Lent Asset Management Inc.’s holdings in Intuitive Surgical were worth $13,994,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the fourth quarter valued at $36,000. Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical in the third quarter worth $38,000. Finally, DT Investment Partners LLC raised its stake in shares of Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,509 shares of company stock valued at $22,602,212 over the last 90 days. 0.80% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $604.12 on Wednesday. The company’s fifty day moving average price is $541.80 and its 200-day moving average price is $500.76. The firm has a market capitalization of $215.18 billion, a price-to-earnings ratio of 97.13, a PEG ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $362.14 and a one year high of $606.27.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ISRG. Piper Sandler reiterated an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Robert W. Baird lifted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Raymond James raised their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Finally, Wells Fargo & Company increased their target price on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Check Out Our Latest Stock Report on ISRG

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.